Hypericum perforatum attenuates the development of carrageenan-induced lung injury in mice

Free Radical Biology and Medicine

Volumn 40, Issue 5, 2006, Pages 740-753

  Menegazzi, Marta ^a   Di Paola, Rosanna ^b   Mazzon, Emanuela ^b   Muià, Carmelo ^b   Genovese, Tiziana ^b   Crisafulli, Concetta ^b   Suzuki, Hisanori ^a   Cuzzocrea, Salvatore ^b  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Carrageenan induced pleurisy; Hypericum perforatum; Myeloperoxidase (MPO) activity; NF B, nuclear factor B; ROS, reactive oxygen species

Indexed keywords

3 NITROTYROSINE; CARRAGEENAN; HYPERICUM PERFORATUM EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; POLY(ADENOSINE DIPHOSPHATE RIBOSE); STAT3 PROTEIN; THIOBARBITURIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIQUID; LUNG INJURY; LUNG PARENCHYMA; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PLEURA CAVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; CARRAGEENAN; HYPERICUM; INTERLEUKIN-1; LIPID PEROXIDATION; LUNG; MALE; MICE; NEUTROPHILS; NF-KAPPA B; PEROXIDASE; PLANT EXTRACTS; PLEURISY; PNEUMONIA; POLY ADENOSINE DIPHOSPHATE RIBOSE; STAT3 TRANSCRIPTION FACTOR;

ANIMALIA; HYPERICUM PERFORATUM;

EID: 33644662292     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2005.08.034     Document Type: Article

References (74)

1. Y.K. Youn, C. Lalonde, and R. Demling Use of antioxidant therapy in shock and trauma Circ. Shock 35 1991 245 249
2. J. Mccord Oxygen-derived free radicals New Horizons 1 1993 70 76
3. S. Cuzzocrea, D.P. Riley, A.P. Caputi, and D. Salvemini Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury Pharmacol. Rev. 53 2001 135 159
4. M.T. Droy-Lefaix, Y. Drouet, G. Geraud, D. Hosfod, and P. Braquet Superoxide dimutase (SOD) and the PAF-antagonist (BN 52021) reduce small intestinal damage induced by ischemia-reperfusion Free Radic. Res. Commun. 13 1991 725 735
5. E. Haglind, G. Xia, and R. Rylander Effects of antioxidants and PAF receptor antagonist in intestinal shock in the rat Circ. Shock 42 1994 83 91
6. Z.F. Xia, M. Hollyoak, R.E. Barrow, F. He, M.J. Muller, and D.N. Herndon Superoxide dismutase and leupeptin prevent delayed reperfusion injury in the rat small intestine during burn shock J. Burn Care Rehab. 16 1995 111 117
7. J.C. Fantone, and P.A. Ward A review: role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions Am. J. Pathol. 107 1982 395 418
8. Y. Li, A. Ferrante, A. Poulos, and D.P. Harvey Neutrophil oxygen radical generation. Synergistic responses to tumor necrosis factor and mono/polyunsaturated fatty acids J. Clin. Invest. 97 1996 (Apr.) 1605 1609
9. N.K. Boughton-Smith, S.M. Evans, F. Laszlo, B.J. Whittle, and S. Moncada The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat Br. J. Pharmacol. 110 1993 1189 1195
10. D. Salvemini, M.P. Jensen, D.P. Riley, and T.P. Misko Therapeutic manipulations of peroxynitrite Drug News Perspect. 11 1998 204 214
11. T.A. Dix, K.M. Hess, M.A. Medina, R.W. Sullivan, S.L. Tilly, and T.L.L. Webb Mechanism of site-selective DNA nicking by the hydrodioxyl (perhydroxyl) radical Biochemistry 35 1996 4578 4583
12. J.S. Beckman, T.W. Beckman, J. Chen, P.A. Marshalland, and B. Freeman Apparent hydroxyl radical production by peroxynitrite: implication for endothelial injury from nitric oxide and superoxide Proc. Natl. Acad. Sci. USA 87 1990 1620 1624
13. H. Ischiropoulos, L. Zhu, and I.S. Beckman Peroxynitrite formation from macrophage-derived nitric oxide Arch. Biochem. Biophys. 298 1992 446 451
14. J.S. Beckman, and L.P. Crow Pathological implications of nitric oxide, superoxide and peroxynitrite formation Biochem. Soc. Trans. 21 1993 330 334
15. D. Salvemini, E. Mazzon, L. Dugo, D.P. Riley, I. Serraino, A.P. Caputi, and S. Cuzzocrea Pharmacological manipulation of the inflammatory cascade by the superoxide dismutase mimetic, M40403 Br. J. Pharmacol. 132 2001 815 827
16. R.T. Peters, S.M. Liao, and T. Maniatis IKKepsilon is part of a novel PMA-inducible IkappaB kinase complex Mol. Cell 5 2000 513 522
17. A. Bowie, and L.A. O'neill Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries Biochem. Pharmacol. 59 2000 13 23
18. F.W. Sunderman The extended therapeutic role of dithiocarb (sodium diethyldithiocarbamate) from nickel poisoning to AIDS Ann. Clin. Lab. Sci. 22 1992 245 248
19. A.S. Baldwin Jr. Series introduction: the transciption factor NF-kB and human disease J. Clin. Invest. 107 2001 3 6
20. M.D. Schwartz, E.E. Moore, F.A. Moore, R. Shenkar, P. Moine, J.B. Haenel, and E. Abraham Nuclear factor-kappa B is activated in alveolar macrophages from patients with the acute respiratory distress syndrome Crit. Care Med. 24 1996 1285 1292
21. E. Pfitzner, S. Kliem, D. Baus, and C.M. Litterst The role of STATs in inflammation and inflammatory diseases Curr. Pharm. Des. 10 2004 2839 2850
22. J.E. Darnell, I.M. Kerr, and G.R. Stark JAK-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins Science 264 1994 1415 1421
23. D.E. Levy, and C.K. Lee What does STAT-3 do? J. Clin. Invest. 109 2002 1143 1148
24. S. Cuzzocrea, L. Sautebin, G. De Sarro, G. Costantino, L. Rombolà, E. Mazzon, A. Ialenti, A. De Sarro, G. Ciliberto, M. Di Rosa, A.P. Caputi, and C. Thiemermann Role of IL-6 in the pleurisy and lung injury caused by carrageenan J. Immunol. 163 1999 5094 5104
25. J. Barnes, L.A. Anderson, and J.D. Phillipson St. John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties J. Pharm. Pharmacol. 53 2001 583 600
26. A. Saija, M. Scalese, M. Lanza, D. Marzullo, F. Bonina, and F. Castelli Flavonoids as antioxidant agents: importance of their interaction with biomembranes Free Radic. Biol. Med. 19 1995 481 486
27. H.M. Abd El-Gawad, and A.E. Khalifa Quercetin, coenzyme Q10, and L-canavanine as protective agents against lipid peroxidation and nitric oxide generation in endotoxin-induced shock in rat brain Pharmacol. Res. 43 2001 257 263
28. O.A. Flausino Jr., H. Zangrossi Jr., J.V. Salgado, and M.B. Viana Effects of acute and chronic treatment with Hypericum perforatum L. (LI 160) on different anxiety-related responses in rats Pharmacol. Biochem. Behav. 71 2002 259 265
29. M. Couladis, I.B. Chinou, O. Tzakou, and P.V. Petrakis Composition and antimicrobial activity of essential oil of Hypericum rumeliacum subsp. apollinis (Boiss and Heldr.) Phytother. Res. 17 2003 152 154
30. E. Tedeschi, M. Menegazzi, D. Margotto, H. Suzuki, U. Förstermann, and H. Kleinert Anti-inflammatory actions of St. John's Wort: inhibition of human inducible nitric-oxide synthase expression by down-regulating signal transducer and activator of transcription-1α (STAT-1) activation J. Pharmacol. Exp. Therapeut. 307 2003 254 261
31. B. Vitiello Hypericum perforatum extracts as potential antidepressants J. Pharm. Pharmacol. 51 1999 513 517
32. S. Kasper Hypericum perforatum-A review of clinical studies Pharmacopsychiatry 34 1 2001 S51 S55
33. G.M. Raso, M. Pacilio, G. DiCarlo, E. Esposito, L. Pinto, and R. Meli In vivo and in vitro anti-inflammatory effect of echinacea purpurea and Hipericum perforatum J. Pharm. Pharmacol. 54 2002 1379 1383
34. K.M. Mullane, R. Kraemer, and B. Smith Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium J. Pharmacol. Meth. 14 1985 157 167
35. E. Schreiber, P. Matthias, M.M. Muller, and W. Schaffner Rapid detection of octamer binding proteins with miniextracts prepared from a small number of cell Nucleic Acids Res. 17 1989 6419A
36. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
37. M. Palmieri, M.P. Sasso, R. Monese, M. Merola, L. Faggioli, M. Tovey, and A. Furia Interaction of the nuclear factor protein CBF-1 with the κB site of the IL-6 gene promoter Nucleic. Acids Res. 27 1999 2785 2791
38. G. Di Carlo, F. Borrelli, E. Ernest, and A.A. Izzo St. John's wort: Prozac from the plant kingdom Trends Pharmacol. Sci. 22 2001 292 297
39. V. Butterweck, V. Christoffel, A. Nahrstedt, F. Petereit, B. Spengler, and H. Winterhoff Step by step removal of hyperforin and hypericin: activity profile of different Hypericum preparations in behavioral models Life Sci. 73 2003 627 639
40. J.R.T. Davidson, T.M. Gadde, J.A. Fairbank, K.R.R. Krishnan, and R.M. Califf Effects of Hypericum perforatum (St. John's Wort) in major depression disorder: a randomized controlled trial J. Am. Med. Assoc. 287 2002 1807 1814
41. A. Singh, P.S. Naidu, S. Gupta, and S.K. Kulkarni Effect of natural and synthetic antioxidants in a mouse model of chronic fatigue syndrome J. Med. Food 5 2002 211 220
42. E.J. Hunt, C.E. Lester, E.A. Lester, and R.L. Tackett Effect of St. John's wort on free radical production Life Sci. 69 2001 181 190
43. B.D. Sloley, and L.J. Urichuk Chemical and pharmacological evaluation of Hypericum perforatum extracts Acta Pharmacol. Sin. 21 2000 1145 1152
44. S. Ghosh, and D. Baltimore Activation in vitro of NF-kB by phosphorylation of its inhibitor IkB Nature 344 1990 678 682
45. R. Kolesnick, and D.W. Goled The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling Cell 77 1994 325 328
46. S. Schultze, T. Machleid, and M. Kronke The role of diacylglycerol and ceramide in tumor necrosis factor and interleukin-1 signal transduction J. Leukoc. Biol. 56 1994 533 541
47. Z.J. Chen, L. Parent, and T. Maniatis Site-specific phosphorylation of I kappa B alpha by a novel ubiquitination-dependent protein kinase activity Cell 84 1996 853 862
48. S.F. Liu, X. Ye, and A.B. Malik In vivo inhibition of nuclear factor-kB activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock J. Immunol. 159 1997 3976 3983
49. C. Munoz, D. Pascual-Salcedo, M.C. Castellanos, A. Alfranca, J. Aragones, and A. Vara Pyrrolidine dithiocarbamate inhibits the production of interleukin-6, interleukin-8, and granulocyte-macrophage colony-stimulating factor by human endothelial cells in response to inflammatory mediators: modulation of NF-kB and AP-1 transcription factors activity Blood 88 1996 3482 3490
50. Q.W. Xie, Y. Kashiwabara, and C. Nathan Role of transcription factor NF-kB/Rel in induction of nitric oxide synthase J. Biol. Chem. 269 1994 4705 4708
51. M.A. Collart, P.A. Bauerle, and P. Vassalli Regulation of tumour necrosis factor alpha transcription in macrophages: involvement of four kB-like motifs and inducible forms of NF-kB Mol. Cell. Biol. 10 1990 1490 1506
52. P.J. Barnes, and M. Karin Nuclear factor k B-A pivotal transcription factor in chronic inflammatory disease N. Eng. J. Med. 336 1997 1066 1071
53. P.A. Bauerle, and T. Henkel Function and activation of NF-kB in the immune system Annu. Rev. Immunol. 2 1994 141 179
54. H. Ruetten, and C. Thiemermann Effect of calpain inhibitor I, an inhibitor of the proteolysis of IkB, on the circulatory failure and multiple organ dysfunction caused by endotoxin in the rat Br. J. Pharmacol. 121 1997 695 704
55. M.L. Roberts, and L.M. Cowsert Interleukin-1 beta and reactive oxygen species mediate activation of c-Jun NH2-terminal kinases, in human epithelial cells, by two independent pathways Biochem. Biophys. Res. Commun. 251 1998 166 172
56. L. Flohe, R. Brigelius-Flohe, C. Saliou, M.G. Traber, and L. Packer Redox regulation of NF-kB activation Free Radic. Biol. Med. 22 1997 1115 1126
57. S. Cuzzocrea, B. Pisano, L. Dugo, A. Ianaro, N.S. Patel, A.P. Caputi, and C. Thiemermann Tempol reduces the activation of nuclear factor-kappaB in acute inflammation Free Radic. Res. 38 8 2004 813 819
58. B. Henderson, and E.R. Pettipher Arthritogenic actions of recombinant IL-1 and tumour necrosis factor a in the rabbit: evidence for synergistic interactions between cytokines in vivo Clin. Exp. Immunol. 75 1989 306 310
59. P.F. Piguet, G.E. Grau, C. Vesin, H. Loetscher, R. Genz, and W. Lesslauer Evolution of collagen arthritis is arrested by treatment with anti-tumour necrosis factor (TNF) antibody or a recombinant soluble TNF receptor J. Immunol. 77 1992 510 514
60. J. Saklatvala Tumour necrosis factor a stimulates resorption and inhibits synthesis of proteoglycan in cartilage Nature 322 1986 547 549
61. P.H. Wooley, J.L. Whalen, D.L. Chapman, A.E. Berger, K.A. Richard, D.G. Aspar, and N.D. Staite The effect of an interleukin-1 receptor antagonist protein on type II collagen-induced arthritis and antigen-induced arthritis in mice Arthritis Rheum. 36 1993 1305 1314
62. B.S. Wung, C.W. Ni, and D.L. Wang ICAM-1 induction by TNF-alpha and IL-6 is mediated by distint pathway via Rac in endothelial cells J. Biomed. Sci. 12 2005 91 101
63. D.K. Wooten, X. Xie, D. Bartos, R.A. Busche, G.D. Longmore, and S.S. Watowich Cytokine signaling through STAT-3 activates integrins, promoter adhesion, and induces growth arrest in myeloid cell line 32D J. Biol. Chem. 275 2000 26566 26575
64. P.C. Heinrich, I. Behrmann, S. Haan, H.M. Hermanns, G. Muller-Newen, and F. Schaper Principles of interleukin (IL)-6-type cytokine signalling and its regulation Biochem. J. 374 2003 1 20
65. A.R. Simon, U. Rai, B.L. Fanburg, and B.H. Cochran Activation of the JAK-STAT pathway by reactive oxygen species Am. J. Physiol. 275 1998 C1640 C1652
66. M. Carballo, M. Conde, R. El Bekay, J. Martin-Nieto, M.J. Camacho, J. Monteseirin, J. Conde, F.J. Bedoya, and F. Sobino Oxidative stress triggers STAT-3 tyrosine phosphorylation and nuclear translocation in human lymphocytes J. Biol. Chem. 274 1999 17580 17586
67. J. Heilmann, K. Winkelmann, and O. Sticher Studies on the antioxidative activity of phloroglucinol derivatives isolated from hypericum species Planta Med. 69 2003 202 206
68. K. Ishige, D. Schubert, and Y. Sagara Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms Free Radic. Biol. Med. 30 2001 433 446
69. J.S. Beckman Oxidative damage and tyrosine nitration from peroxynitrite Chem. Res. Toxicol. 9 1996 836 844
70. J.P. Eiserich, M. Hristova, C.E. Cross, A.D. Jones, B.A. Freeman, B. Halliwell, and A. Van Der Vliet Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils Nature 391 1998 393 397
71. S. Cuzzocrea, B. Zingarelli, E. Gilard, P. Hake, A.L. Salzman, and C. Szabó Protective effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthase in carrageenan-induced models of local inflammation Eur. J. Pharmacol. 342 1998 67 76
72. S. Cuzzocrea, B. Zingarelli, E. Gilard, P. Hake, A.L. Salzman, and C. Szabò Anti-inflammatory effects of mercaptoethylguanidine, a combined inhibitor of nitric oxide synthase and peroxynitrite scavenger in carrageenan-induced models of inflammation Free Radic. Biol. Med. 24 1998 450 459
73. C. Szabó, L.H.K. Lim, S. Cuzzocrea, S.J. Getting, B. Zingarelli, R.J. Flower, A.L. Salzman, and M. Perretti Inhibition of poly (ADP-ribose) synthetase exerts anti-inflammatory effects and inhibits neutrophil recruitment J. Exp. Med. 186 1997 1041 1049
74. C. Szabò, L. Virag, S. Cuzzocrea, G.S. Scott, P. Hake, M. O'connor, B. Zingarelli, Y. Ma, R. Hirsch, G.P. Boiovin, A.L. Salzman, and E. Kun Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly (ADP-ribose) synthetase Proc. Natl. Acad. Sci. USA 95 1998 3867 3872